Abstract
The aim of many microarray experiments is to build discriminatory diagnosis and prognosis models. A large number of supervised methods have been proposed in literature for microarray-based classification. Model comparison, which is based on the classification error estimation, is a critical issue. Previous studies have shown that error estimation is unreliable in high-dimensional small-sample settings. This leads naturally to questioning the validity of classificationrule comparison approaches being used in the literature. In this paper we present a brief review of the different comparison methods used in bioinformatics. Then, we test these methods on a set of simulations based on both synthetic and real data. These simulations include different feature-label distributions, classification rules, error estimators and variance estimators. The results show that none of these methods can provide reliable comparison across a wide spectrum of feature-label distributions and classification rules.
Keywords: Microarray classification, error estimation, classifier comparison, variance study
Current Bioinformatics
Title: On the Comparison of Classifiers for Microarray Data
Volume: 5 Issue: 1
Author(s): Blaise Hanczar and Edward R. Dougherty
Affiliation:
Keywords: Microarray classification, error estimation, classifier comparison, variance study
Abstract: The aim of many microarray experiments is to build discriminatory diagnosis and prognosis models. A large number of supervised methods have been proposed in literature for microarray-based classification. Model comparison, which is based on the classification error estimation, is a critical issue. Previous studies have shown that error estimation is unreliable in high-dimensional small-sample settings. This leads naturally to questioning the validity of classificationrule comparison approaches being used in the literature. In this paper we present a brief review of the different comparison methods used in bioinformatics. Then, we test these methods on a set of simulations based on both synthetic and real data. These simulations include different feature-label distributions, classification rules, error estimators and variance estimators. The results show that none of these methods can provide reliable comparison across a wide spectrum of feature-label distributions and classification rules.
Export Options
About this article
Cite this article as:
Hanczar Blaise and Dougherty R. Edward, On the Comparison of Classifiers for Microarray Data, Current Bioinformatics 2010; 5 (1) . https://dx.doi.org/10.2174/157489310790596376
DOI https://dx.doi.org/10.2174/157489310790596376 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antithrombin, an Important Inhibitor in Blood Clots
Current Topics in Medicinal Chemistry Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Activin Receptor-Like Kinases: Structure, Function and Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Development of Specific New ELISA for Bioanalysis of Cetuximab: A Monoclonal Antibody Used for Cancer Immunotherapy
Current Pharmaceutical Analysis Oncolytic Virotherapy for Breast Cancer Treatment
Current Gene Therapy Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy
Mini-Reviews in Medicinal Chemistry The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Current Pharmaceutical Design Molecular Mechanism of Deguelin in Anti-tumor Effect
Current Pharmaceutical Analysis GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Current Medicinal Chemistry MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond
Anti-Cancer Agents in Medicinal Chemistry Ghrelin and the Brain-gut Axis as a Pharmacological Target for Appetite Control
Current Pharmaceutical Design Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids
Current Medicinal Chemistry Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies
Current Pharmacogenomics and Personalized Medicine Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Current Molecular Medicine Ghrelin and Energy Balance: Focus on Current Controversies
Current Drug Targets Effect of Pregnenolone Derivatives on the Selective Inhibition of 5α-Reductase 2 Activity
Current Enzyme Inhibition